Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Neeta B. Amin, Robert Frederich, Nikolaos Tsamandouras, Amina Z. Haggag, Tilman Schuster, Witold Zmuda, Alexandra Palmer, Szilard Vasas, Gina Buckley, Timothy R. Smith, Sarah J. DuBrava, Qi Zhu, Margot Johnson
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet